EuroIntervention

Scope & Guideline

Transforming Research into Clinical Impact in Cardiology

Introduction

Welcome to the EuroIntervention information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of EuroIntervention, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1774-024x
PublisherEUROPA EDITION
Support Open AccessNo
CountryFrance
TypeJournal
Convergefrom 2008 to 2024
AbbreviationEUROINTERVENTION / EuroIntervention
Frequency-
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address19 ALLEES JEAN JAURES B P 61508, TOULOUSE CEDEX 6 31015, FRANCE

Aims and Scopes

EuroIntervention focuses on advancing the field of interventional cardiovascular medicine, particularly through innovative techniques and devices for managing coronary and valvular heart diseases.
  1. Transcatheter Aortic Valve Implantation (TAVI):
    The journal frequently publishes studies on TAVI, exploring its effectiveness, complications, and advancements in valve technology.
  2. Percutaneous Coronary Intervention (PCI):
    Research on PCI techniques, including stenting, drug-coated balloons, and the management of complications, is a core focus area.
  3. Innovative Devices and Techniques:
    The journal highlights novel devices and methodologies, such as robotic assistance in procedures, and new stent technologies.
  4. Clinical Outcomes and Predictive Models:
    Studies assessing the long-term outcomes of various interventions and the development of predictive models for patient outcomes are prevalent.
  5. Antithrombotic Therapy:
    Exploration of antithrombotic strategies, including dual antiplatelet therapy (DAPT) and its implications in different patient populations.
  6. Valvular Heart Disease Interventions:
    Research on interventions for mitral and tricuspid valve diseases, including edge-to-edge repair techniques, is also prominent.
EuroIntervention has identified several emerging research themes that reflect the current trends in interventional cardiovascular medicine, driven by technological advancements and evolving clinical practices.
  1. Hybrid Approaches to Treatment:
    There is a growing interest in hybrid therapies that combine surgical and percutaneous methods, particularly in complex cases involving multi-valvular disease.
  2. Use of Artificial Intelligence (AI):
    AI applications in predicting outcomes, optimizing procedures, and enhancing imaging analysis are increasingly featured in recent publications.
  3. Patient-Centric Approaches:
    Research focusing on patient-reported outcomes, shared decision-making, and personalized treatment plans is on the rise, emphasizing the importance of patient preferences in clinical practice.
  4. Long-term Durability of Devices:
    Studies investigating the long-term performance and outcomes of newer devices, especially bioresorbable scaffolds and advanced stenting platforms, are gaining traction.
  5. Management of Non-Obstructive Coronary Artery Disease (MINOCA):
    An increasing number of studies are focusing on the diagnosis and management strategies for MINOCA, reflecting a shift towards understanding this complex condition.

Declining or Waning

While EuroIntervention continues to thrive in many areas, certain themes have seen a decline in prominence, reflecting shifts in clinical practice and research focus.
  1. Traditional Surgical Techniques:
    There has been a noticeable decrease in publications focused solely on traditional surgical interventions, as the field shifts towards less invasive, transcatheter approaches.
  2. Conventional Imaging Techniques:
    Research dedicated to older imaging modalities is waning in favor of advanced intravascular imaging techniques like optical coherence tomography (OCT) and intravascular ultrasound (IVUS).
  3. General Antithrombotic Guidelines:
    Specific guidelines that do not account for individual patient risk profiles are becoming less common, as personalized medicine approaches gain traction.
  4. Single Antiplatelet Therapy:
    There is a declining emphasis on the use of single antiplatelet therapy, especially in high-risk populations, with more focus on tailored DAPT strategies.
  5. Pharmacological Approaches in Isolation:
    Research that does not integrate procedural techniques with pharmacological management is becoming less frequent, as a more holistic approach is favored.

Similar Journals

JOURNAL OF INVASIVE CARDIOLOGY

Leading the Conversation in Invasive Cardiology
Publisher: H M P COMMUNICATIONSISSN: 1042-3931Frequency: 12 issues/year

JOURNAL OF INVASIVE CARDIOLOGY, a reputable publication by H M P COMMUNICATIONS, is dedicated to advancing the field of cardiology and cardiovascular medicine through rigorous research and scholarly discussion. With an ISSN of 1042-3931 and an E-ISSN of 1557-2501, this journal serves as a crucial resource for healthcare professionals, researchers, and students who seek to stay informed about the latest findings and innovations in invasive cardiology. Having achieved a 2023 Scopus rank of #185 out of 636 in General Medicine, placing it in the 70th percentile, the journal is recognized for its significant contributions to medical science, evidenced by its Q2 ranking in Radiology, Nuclear Medicine and Imaging, and Q3 status in both Cardiology and Cardiovascular Medicine. The journal has been in circulation since 1990 and continues to foster a platform for critical research in the United States, ensuring accessibility to vital information necessary for enhancing patient care and clinical practices within the domain of invasive procedures.

Kardiologie

Innovating Heart Health: Where Research Meets Clinical Practice.
Publisher: SPRINGER HEIDELBERGISSN: 2731-7129Frequency: 6 issues/year

Kardiologie is an emerging journal dedicated to advancing the field of cardiology and cardiovascular medicine, published by SPRINGER HEIDELBERG in Germany. Established with the first issue in 2022, this journal provides a valuable platform for the dissemination of innovative research, clinical studies, and review articles that contribute to both theoretical knowledge and practical applications in cardiology. While the journal currently holds a Q4 category ranking in the field and occupies a percentile of 24 according to Scopus, it aims to enhance its impact factor by attracting high-quality submissions from researchers and clinicians alike. Kardiologie is particularly focused on bridging the gap between cutting-edge research and clinical practice, ensuring that the latest scientific findings are readily accessible to practitioners. Though it operates under traditional access options at present, the journal aspires to broaden its accessibility and reach in future editions, making it a pertinent choice for anyone interested in the evolving landscape of cardiovascular health.

CURRENT PROBLEMS IN CARDIOLOGY

Pioneering Solutions for Modern Cardiovascular Issues
Publisher: MOSBY-ELSEVIERISSN: 0146-2806Frequency: 12 issues/year

CURRENT PROBLEMS IN CARDIOLOGY is a leading peer-reviewed journal published by MOSBY-ELSEVIER, dedicated to advancing the field of cardiology through comprehensive analyses of contemporary challenges faced by cardiovascular practitioners. With its ISSN 0146-2806 and E-ISSN 1535-6280, this esteemed journal has been a crucial resource for researchers, clinicians, and students alike since its inception in 1976, and continues to publish groundbreaking studies and reviews up until 2024. As a testament to its scholarly impact, CURRENT PROBLEMS IN CARDIOLOGY boasts a prestigious Q1 ranking in both Cardiology and Cardiovascular Medicine, as well as in the broader category of Medicine (miscellaneous) in the 2023 metrics, positioning it among the top journals in its field. With a Scopus ranking of #127 out of 387 in Cardiology, and a 67th percentile ranking, it remains a vital platform for disseminating high-quality research that addresses critical issues in cardiovascular health. Researchers and practitioners looking to stay at the forefront of cardiac medicine will find this journal an indispensable tool for informed decision-making and practice improvement.

Journal of Cardiovascular Medicine

Innovating Heart Health Through Groundbreaking Studies
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1558-2027Frequency: 12 issues/year

Welcome to the Journal of Cardiovascular Medicine, a leading platform for the dissemination of high-quality research in the field of cardiology and cardiovascular medicine. Published by Lippincott Williams & Wilkins, this esteemed journal boasts an ISSN of 1558-2027 and an E-ISSN of 1558-2035, reflecting its commitment to accessible and innovative cardiovascular research. With a significant impact factor and ranked Q2 in both Cardiology and Cardiovascular Medicine as well as in Medicine (Miscellaneous) for 2023, the journal is recognized for its contributions to advancing knowledge and practice in this critical area of health. The journal disseminates original research, reviews, and clinical studies, aimed at clinicians, researchers, and healthcare professionals who are dedicated to improving cardiovascular health outcomes. With a continuous commitment to evolving research from 2006 to 2024, the journal is an essential resource for those looking to stay at the forefront of the latest discoveries and methodologies in cardiovascular medicine.

Cardiology Journal

Elevating standards in heart health scholarship.
Publisher: VIA MEDICAISSN: 1897-5593Frequency: 6 issues/year

Cardiology Journal, published by VIA MEDICA, stands as a prominent resource in the field of cardiology and cardiovascular medicine, with an ISSN of 1897-5593 and an E-ISSN of 1898-018X. Recognized for its Open Access model established since 1994, this journal facilitates widespread dissemination of critical research findings, allowing practitioners and researchers globally to access valuable insights without barriers. Based in Poland, with an address at UL SWIETOKRZYSKA 73, 80-180 GDANSK, it has achieved a respectable Q2 classification in 2023 for both Cardiology and Miscellaneous Medicine categories, reflecting its influence and quality within the scholarly community. With a Scopus ranking placing it at #117 out of 387 in Cardiology, it lies within the 69th percentile, underpinning its commitment to advancing knowledge in cardiovascular health. The journal’s converged years extending from 2006 to 2024 ensure it captures ongoing developments in a rapidly evolving field. As such, the Cardiology Journal serves as an indispensable platform for researchers, professionals, and students dedicated to exploring the frontiers of cardiac science and improving patient care.

Indian Heart Journal

Empowering Research to Transform Cardiac Care
Publisher: ELSEVIERISSN: 0019-4832Frequency: 6 issues/year

Indian Heart Journal, published by Elsevier, is a distinguished peer-reviewed journal dedicated to the field of cardiology and cardiovascular medicine. Founded in 1961, this journal has been a pivotal resource for researchers, healthcare professionals, and students, providing a platform for innovative studies and insights into heart health. The journal transitioned to an Open Access model in 2013, ensuring widespread dissemination of vital research findings to enhance global understanding of cardiovascular diseases. Ranked in the Q3 category for Cardiology and Cardiovascular Medicine in 2023, it holds a reputable position in the medical community, with a Scopus rank of #222 out of 387 journals in the same field, placing it in the 42nd percentile. The Indian Heart Journal strives to foster advances in clinical practice and research while addressing the unique cardiac health challenges faced in India and beyond.

Heart Lung and Circulation

Exploring Innovations in Heart and Lung Health
Publisher: ELSEVIER SCIENCE INCISSN: 1443-9506Frequency: 12 issues/year

Heart Lung and Circulation, published by Elsevier Science Inc, is a premier peer-reviewed journal that focuses on the dynamic fields of cardiology, cardiovascular medicine, and pulmonary and respiratory medicine. With its ISSN 1443-9506 and E-ISSN 1444-2892, this journal has established itself as a significant contributor to the scientific community since its inception in 2000 and continues to publish cutting-edge research through 2024. Ranked in the Q2 category for both Cardiology and Pulmonary and Respiratory Medicine for 2023, it reflects a strong impact within its discipline. While the journal operates under a subscription model, it offers a comprehensive platform for disseminating significant developments, case studies, and reviews pertinent to practitioners, researchers, and students alike. The journal's focus on bridging the gaps in knowledge surrounding heart and lung physiology underscores its vital role in enhancing patient care and informing clinical practices.

Postepy w Kardiologii Interwencyjnej

Advancing interventional cardiology through open access insights.
Publisher: TERMEDIA PUBLISHING HOUSE LTDISSN: 1734-9338Frequency: 4 issues/year

Postepy w Kardiologii Interwencyjnej is a prominent scholarly journal dedicated to the field of interventional cardiology, published by the esteemed TERMEDIA PUBLISHING HOUSE LTD. Since its transition to an Open Access model in 2005, this journal has provided a platform for the dissemination of valuable research and clinical insights, reaching a broad audience of researchers, healthcare professionals, and students in Poland and beyond. With an ISSN of 1734-9338 and E-ISSN of 1897-4295, the journal has established its relevance by featuring articles that are currently indexed in Scopus, reflecting its impact in the field, particularly with a rank of #269 out of 387 in the category of Cardiology and Cardiovascular Medicine for 2023. The publication has continuously evolved to meet the demands of the scientific community, making it an essential resource for staying informed about the latest advancements in interventional techniques and cardiology research. With its commitment to enhancing the knowledge base of cardiovascular medicine, Postepy w Kardiologii Interwencyjnej plays a critical role in fostering collaboration and innovation within this vital specialty.

Anatolian Journal of Cardiology

Connecting Global Hearts with Cutting-edge Cardiovascular Knowledge.
Publisher: KARE PUBLISSN: 2149-2263Frequency: 12 issues/year

The Anatolian Journal of Cardiology, published by KARE PUBL, stands as a vital resource in the field of Cardiology and Cardiovascular Medicine. With an ISSN of 2149-2263 and E-ISSN 2149-2271, this Open Access journal has been fostering the dissemination of critical research since 2001, ensuring that high-quality content is freely available to a global audience. Based in Turkey, the journal aims to bridge gaps in cardiological knowledge through rigorous peer-reviewed articles that span a wide range of topics, from innovative clinical practices to groundbreaking research findings. While its current ranking places it in the Q3 category of cardiology journals, the Anatolian Journal of Cardiology continues to strive towards enhancing its impact, currently holding a Scopus rank of 236 out of 387. Researchers, practitioners, and students alike will find this journal an essential platform for keeping abreast of the latest developments in cardiovascular health.

Cardiovascular Intervention and Therapeutics

Championing excellence in cardiovascular intervention and therapeutics.
Publisher: SPRINGER JAPAN KKISSN: 1868-4300Frequency: 4 issues/year

Cardiovascular Intervention and Therapeutics, published by SPRINGER JAPAN KK, stands as a prominent journal within the fields of cardiology and cardiovascular medicine, reflecting its commitment to disseminating groundbreaking research and clinical advances. With an impressive Q2 ranking in Cardiology and Cardiovascular Medicine as well as in Medicine (miscellaneous), and a Q1 ranking in Radiology, Nuclear Medicine and Imaging, this journal employs rigorous peer-review processes to ensure the quality and relevance of its content. Catering to a diverse audience of researchers, clinicians, and students, the journal aims to foster innovation and enhance understanding through the publication of original research, reviews, and clinical studies focused on cardiovascular interventions and therapies. Spanning over a decade of evolution from 2010 to 2024, Cardiovascular Intervention and Therapeutics continues to be a vital resource for advancing knowledge and practice in the cardiovascular field. Explore the latest advancements and insights that this esteemed journal has to offer, and contribute to the ongoing dialogue that shapes modern cardiovascular medicine.